Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting primary and secondary mediation analyses of randomised trials and observational studies.|
|Full bibliographic reference||Lee H, Cashin AG, Lamb SE, Hopewell S, Vansteelandt S, VanderWeele TJ, MacKinnon DP, Mansell G, Collins GS, Golub RM, McAuley JH; AGReMA group, Localio AR, van Amelsvoort L, Guallar E, Rijnhart J, Goldsmith K, Fairchild AJ, Lewis CC, Kamper SJ, Williams CM, Henschke N. A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies: The AGReMA Statement. JAMA. 2021;326(11):1045-1056.|
(full-text if available)
|Access the AGReMA checklist for reporting mediation analyses of randomised controlled trials and observational studies as a primary objective.
Access the AGReMA-SF checklist for reporting secondary mediation analyses within primary reports of randomised controlled trials and observational studies.
|Reporting guideline website URL||https://agrema-statement.org/|
|Reporting guideline acronym||AGReMA|
|Study design||Clinical trials, Experimental studies, Observational studies|
|Applies to the whole report or to individual sections of the report?||Statistical methods and analyses|
|Additional information||Read about the development of the AGReMA reporting guideline.|
|Record last updated on||September 23, 2021|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.
For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.
Visit our Help page for information about searching for reporting guidelines and for general information about using our website.